Sökresultat - Green, Damian
- Visas 1 - 20 av 64 resultat
- Gå till nästa sida
-
1
-
2
-
3
-
4
-
5
-
6
Bortezomib and Fenretinide Induce Synergistic Cytotoxicity in Mantle Cell Lymphoma Via Apoptosis, Cell Cycle Dysregulation, and IκBα Kinase Down-regulation av Cowan, Andrew J., Frayo, Shani L., Press, Oliver W., Palanca-Wessels, Maria C., Pagel, John M., Green, Damian J., Gopal, Ajay K.
Publicerad 2015Text -
7
Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenström macroglobulinemia: evidence for a graft-versus-lymphoma effect av Maffini, Enrico, Anderson, Larry D., Sandmaier, Brenda M., Green, Damian J., Storer, Barry E., Niederwieser, Dietger, Maziarz, Richard T., Maloney, David G., Storb, Rainer
Publicerad 2018Text -
8
Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma av Coffey, David G., Wu, Qian V., Towlerton, Andrea M. H., Ornelas, Sharon, Morales, Alicia J., Xu, Yuexin, Green, Damian J., Warren, Edus H.
Publicerad 2019Text -
9
Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma av Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Publicerad 2018Text -
10
Computer-Assisted Diagnostic Coding: Effectiveness of an NLP-based approach using SNOMED CT to ICD-10 mappings av Nguyen, Anthony N., Truran, Donna, Kemp, Madonna, Koopman, Bevan, Conlan, David, O’Dwyer, John, Zhang, Ming, Karimi, Sarvnaz, Hassanzadeh, Hamed, Lawley, Michael J., Green, Damian
Publicerad 2018Text -
11
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patie... av Gopal, Ajay K., Tarantolo, Stefano R., Bellam, Naresh, Green, Damian J., Griffin, Melissa, Feldman, Tatyana, Mato, Anthony R., Eisenfeld, Amy J., Stromatt, Scott C., Goy, Andre
Publicerad 2014Text -
12
Medication Adherence Assessment: High Accuracy of the New Ingestible Sensor System in Kidney Transplants av Eisenberger, Ute, Wüthrich, Rudolf P., Bock, Andreas, Ambühl, Patrice, Steiger, Jürg, Intondi, Allison, Kuranoff, Susan, Maier, Thomas, Green, Damian, DiCarlo, Lorenzo, Feutren, Gilles, De Geest, Sabina
Publicerad 2013Text -
13
A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations av Pagel, John M., Orgun, Nural, Hamlin, Donald K., Wilbur, D. Scott, Gooley, Theodore A., Gopal, Ajay K., Park, Steven I., Green, Damian J., Lin, Yukang, Press, Oliver W.
Publicerad 2009Text -
14
In vivo Localization of (90)Y- and (177)Lu-Radioimmunoconjugates Using Cerenkov Luminescence Imaging in a Disseminated Murine Leukemia Model av Balkin, Ethan R., Kenoyer, Aimee, Orozco, Johnnie J., Hernandez, Alexandra, Shadman, Mazyar, Fisher, Darrell R., Green, Damian J., Hylarides, Mark D., Press, Oliver W., Wilbur, D. Scott, Pagel, John M.
Publicerad 2014Text -
15
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous... av Cowan, Andrew J., Klippel, Zandra K., Stevenson, Philip A., Hyun, Teresa S., Tuazon, Sherilyn, Becker, Pamela S., Green, Damian J., Holmberg, Leona A., Coffey, David G., Gopal, Ajay K., Libby, Edward N.
Publicerad 2016Text -
16
Long-Term Follow Up of (90)Y-ibritumomab Tiuxetan, Fludarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B-Cell Lymphoma av Puronen, Camille E., Cassaday, Ryan D., Stevenson, Philip A., Sandmaier, Brenda M., Flowers, Mary E., Green, Damian J., Maloney, David G., Storb, Rainer F., Press, Oliver W., Gopal, Ajay K.
Publicerad 2018Text -
17
Eradication of disseminated leukemia in a syngeneic murine leukemia model using pretargeted anti-CD45 radioimmunotherapy av Pagel, John M., Hedin, Nathan, Drouet, Lacey, Wood, Brent L., Pantelias, Anastasia, Lin, Yukang, Hamlin, Donald K., Wilbur, D. Scott, Gopal, Ajay K., Green, Damian, Appelbaum, Frederick R., Press, Oliver W.
Publicerad 2008Text -
18
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma av Green, Damian J., Maloney, David G., Storer, Barry E., Sandmaier, Brenda M., Holmberg, Leona A., Becker, Pamela S., Fang, Min, Martin, Paul J., Georges, George E., Bouvier, Michelle E., Storb, Rainer, Mielcarek, Marco
Publicerad 2017Text -
19
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate with Autologous Stem Cell Support for High-Risk Lymphoma av Cassaday, Ryan D., Press, Oliver W., Pagel, John M., Rajendran, Joseph G., Gooley, Ted A., Fisher, Darrell R., Holmberg, Leona A., Miyaoka, Robert S., Sandmaier, Brenda M., Green, Damian J., Gopal, Ajay K.
Publicerad 2019Text -
20
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma av Green, Damian J., Bensinger, William I., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Pagel, John M., Frayo, Shani L., Roden, Jennifer E., Hedin, Lacey, Press, Oliver W., Gopal, Ajay K.
Publicerad 2016Text